Device Trial Radar · NCT01018888
Safety and Efficacy Study of Artificial Cornea
Last checked: Nov 20, 2026Latest source record: Jan 8, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
20
Planned (sponsor's estimate)
Start
Aug 2010
Primary completion
Jun 2014
Study completion Jul 2014
Sponsor
- Lead sponsor
- AurolabAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 25, 2009
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the stability of artificial cornea manufactured by Aurolab and to assess its visual outcomes.
Conditions
- Corneal Transplantation
Interventions
Auro KPro (Keratoprosthesis)Device
Front plate with optical cylinder, a back plate and a titanium ring to hold the complex together
Primary outcomes
What the sponsor says the trial is designed to measure.
- Visual AcuityTime frame: 1st Month, 2nd Month, 3rd Month,5th Month, 7th Month, 9th Month and 12th Month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Aravind Eye Hospital
Madurai, Tamil Nadu, India · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.